激发性突触传输通过沿着关节通路的阿片类受体以不同的方式调节
Jacob M Reeves1,2, Erwin Arias-Hervert2, Gracianne E Kmiec2
1Neuroscience Graduate Program, University of Michigan, Ann Arbor, Michigan 48109.
eNeuro
|July 16, 2025
概括
阿片类受体 (卡帕,穆和德尔塔) 调节疼痛和情绪电路. 这项研究揭示了卡帕阿片类受体独特地抑制了直接的关节到皮质神经元通信,影响了疼痛感知.
科学领域:
- 神经科学是一个神经科学.
- 神经药理学神经药理学
- 疼痛研究 疼痛研究
背景情况:
- 前带状皮层 (ACC) 和关节层 (CLA) 对于疼痛和情绪处理至关重要.
- 这两个区域都表达Kappa (KOR),Mu (MOR) 和Delta (DOR) 的阿片类受体.
- 由阿片类受体对CLA-ACC电路的精确调节仍然不清楚.
研究的目的:
- 为了研究阿片类受体激活对CLA→ACC电路中的谷氨基基基信号传递的影响.
- 阐明KOR,MOR和DOR在调节CLA-ACC突触传输中的不同作用.
主要方法:
- 在小鼠中利用空间转录学,脑切片电生理学,光遗传学和药理学.
- 在ACC中检查了从CLA到第5层金字塔细胞 (L5 PYR) 的突触传递.
- 评估KOR,MOR和DOR激动剂对刺激反应的影响.
主要成果:
- KOR,MOR和DOR激动剂通常会减少从CLA到ACC L5 PYR细胞的激发性突触传递.
- KOR激动剂独特地减少了单突触传播,表明在直接的CLA→ACC途径中发挥了特定的作用.
- MOR和DOR激动剂主要影响较慢,更长的潜伏时间的复发性兴奋反应.
结论:
- 阿片类受体通过差异性调节关闭性循环.
- 卡帕阿片类受体在调节直接的CLA→ACC突触传播方面发挥着独特的作用.
- 这些发现为阿片类药物调节疼痛和情绪处理网络提供了新的见解.
相关概念视频
Opioid Receptors: Overview
1.9K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.9K
Analgesia and Pain Management
811
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
811
Excitatory and Inhibitory Effects of Neurotransmitters
10.8K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
10.8K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.6K
Neurochemical Transmission: Sites of Drug Action
2.7K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.7K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
455
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
455


